Literature DB >> 12084310

Androgen deficiency in the aging male: when to evaluate and when to treat.

W E Nolten1.   

Abstract

Aging can be associated with an abnormal decline in testosterone production, mainly due to pituitary failure, and is reflected by low serum testosterone concentrations. Manifestations of testosterone deficiency can be subtle, can be misinterpreted as consequences of normal aging, and include lack of libido and energy, mood changes, impaired strength, and development of osteoporosis. The most important factor in the evaluation and treatment of this age-related, usually unrecognized abnormality is the public awareness of its frequent occurrence that will stimulate the use of appropriate screening tests, beginning with a morning testosterone level. Replacement therapy by parenteral or transdermal testosterone administration can be highly beneficial in alleviating the manifestations of hypogonadism and improving quality of life. Careful screening and meticulous follow-up are mandatory. The long-term effects of testosterone replacement on the cardiovascular system, the prostate, and on longevity are unknown.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12084310     DOI: 10.1007/s11934-000-0013-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  42 in total

1.  Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age.

Authors:  P J Snyder; H Peachey; P Hannoush; J A Berlin; L Loh; D A Lenrow; J H Holmes; A Dlewati; J Santanna; C J Rosen; B L Strom
Journal:  J Clin Endocrinol Metab       Date:  1999-08       Impact factor: 5.958

2.  Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study.

Authors:  D Simon; M A Charles; K Nahoul; G Orssaud; J Kremski; V Hully; E Joubert; L Papoz; E Eschwege
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

3.  Testicular endocrine function in the ageing male.

Authors:  A Vermeulen; J P Deslypere
Journal:  Maturitas       Date:  1985-09       Impact factor: 4.342

4.  The measurement of sex steroid binding globulin by differential ammonium sulphate precipitation.

Authors:  S O'Connor; H W Baker; A Dulmanis; B Hudson
Journal:  J Steroid Biochem       Date:  1973-07       Impact factor: 4.292

5.  Adult lean body mass declines with age: some longitudinal observations.

Authors:  G B Forbes; J C Reina
Journal:  Metabolism       Date:  1970-09       Impact factor: 8.694

6.  Occult prostate cancer in men with low serum testosterone levels.

Authors:  A Morgentaler; C O Bruning; W C DeWolf
Journal:  JAMA       Date:  1996-12-18       Impact factor: 56.272

7.  Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity.

Authors:  N Mauras; V Hayes; S Welch; A Rini; K Helgeson; M Dokler; J D Veldhuis; R J Urban
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

8.  The relationship between pituitary-gonadal function and sexual behavior in healthy aging men.

Authors:  R C Schiavi; P Schreiner-Engel; D White; J Mandeli
Journal:  Psychosom Med       Date:  1991 Jul-Aug       Impact factor: 4.312

Review 9.  Age-associated testosterone decline in men: clinical issues for psychiatry.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1998-10       Impact factor: 18.112

10.  Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis.

Authors:  R J Urban; Y H Bodenburg; C Gilkison; J Foxworth; A R Coggan; R R Wolfe; A Ferrando
Journal:  Am J Physiol       Date:  1995-11
View more
  1 in total

1.  Androgen therapy: testing before prescribing and monitoring during therapy.

Authors:  Alan Katz; Anne Katz; Charles Burchill
Journal:  Can Fam Physician       Date:  2007-11       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.